Compare Stocks

→ Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNSP CNS Pharmaceuticals	$0.22 +4.8%	$0.31	$0.19 ▼ $2.98	$2.32M	2.67	359,958 shs	109,097 shs
ENVB Enveric Biosciences	$0.90 -1.1%	$1.05	$0.65 ▼ $6.98	$6.53M	0.85	3.42 million shs	57,769 shs
GRI GRI Bio	0.43 0.0%	0.71	0.41 ▼ 62.23	$1.38M	-1.77	596,077 shs	62,200 shs
NEPT Neptune Wellness Solutions		$0.39	$0.19 ▼ $28.00	$906K	2.19	462,687 shs	2.25 million shs

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNSP CNS Pharmaceuticals	-4.67%	-0.49%	-45.60%	-51.39%	-88.00%
ENVB Enveric Biosciences	-1.77%	-2.19%	-13.44%	+2.23%	-44.73%
GRI GRI Bio	-1.65%	-16.85%	-42.83%	-79.18%	+43,019,900.00%
NEPT Neptune Wellness Solutions	0.00%	0.00%	0.00%	-55.36%	-99.22%

The Next Step of Their Control Is Here … (Ad)

Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.

4 simple steps to protect your privacy and money before it’s too late.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CNSP CNS Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ENVB Enveric Biosciences	2.4452 of 5 stars	3.5	5.0	0.0	0.0	2.2	0.0	0.6
GRI GRI Bio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NEPT Neptune Wellness Solutions	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNSP CNS Pharmaceuticals	N/A	N/A	N/A	N/A
ENVB Enveric Biosciences	3.00	Buy	$10.00	1,017.32% Upside
GRI GRI Bio	N/A	N/A	N/A	N/A
NEPT Neptune Wellness Solutions	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest ENVB, CNSP, GRI, and NEPT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
1/30/2024	ENVB Enveric Biosciences	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy	$10.00

(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNSP CNS Pharmaceuticals	N/A	N/A	N/A	N/A	($0.71) per share	N/A
ENVB Enveric Biosciences	N/A	N/A	N/A	N/A	$0.71 per share	N/A
GRI GRI Bio	N/A	N/A	N/A	N/A	0.40 per share	N/A
NEPT Neptune Wellness Solutions	$52.62M	0.00	N/A	N/A	($91.90) per share	0.00

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNSP CNS Pharmaceuticals	-$18.85M	-$5.66	N/A	∞	N/A	N/A	-603.40%	-421.35%	5/20/2024 (Estimated)
ENVB Enveric Biosciences	-$17.29M	-$8.11	N/A	N/A	N/A	N/A	-349.01%	-187.74%	5/20/2024 (Estimated)
GRI GRI Bio	-$13.04M	-81.48	N/A	∞	N/A	N/A	-795.54%	-345.37%	5/20/2024 (Estimated)
NEPT Neptune Wellness Solutions	-$60.46M	-$106.72	N/A	N/A	N/A	-128.13%	N/A	-141.94%	7/15/2024 (Estimated)

Latest ENVB, CNSP, GRI, and NEPT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/1/2024	Q4 2023	CNSP CNS Pharmaceuticals	N/A	-$0.95	-$0.95	-$0.95	N/A	N/A
3/25/2024	Q4 2023	ENVB Enveric Biosciences	-$1.55	-$1.46	+$0.09	-$1.46	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNSP CNS Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
ENVB Enveric Biosciences	N/A	N/A	N/A	N/A	N/A
GRI GRI Bio	N/A	N/A	N/A	N/A	N/A
NEPT Neptune Wellness Solutions	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNSP CNS Pharmaceuticals	N/A	0.26	0.26
ENVB Enveric Biosciences	N/A	1.53	1.53
GRI GRI Bio	N/A	1.09	1.09
NEPT Neptune Wellness Solutions	N/A	0.23	0.10

Ownership

Institutional Ownership

Company	Institutional Ownership
CNSP CNS Pharmaceuticals	14.02%
ENVB Enveric Biosciences	13.82%
GRI GRI Bio	33.95%
NEPT Neptune Wellness Solutions	14.44%

Insider Ownership

Company	Insider Ownership
CNSP CNS Pharmaceuticals	3.88%
ENVB Enveric Biosciences	1.20%
GRI GRI Bio	16.82%
NEPT Neptune Wellness Solutions	5.10%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CNSP CNS Pharmaceuticals	3	10.64 million	10.22 million	Not Optionable
ENVB Enveric Biosciences	7	7.29 million	7.21 million	Not Optionable
GRI GRI Bio	1	3.20 million	2.66 million	Not Optionable
NEPT Neptune Wellness Solutions	58	4.53 million	4.30 million	Not Optionable

ENVB, CNSP, GRI, and NEPT Headlines

Source	Headline
	Neptune Wellness Solutions (NASDAQ:NEPT) Now Covered by Analysts at StockNews.com americanbankingnews.com - April 16 at 2:22 AM
	Neptune prepared to take legal action against property owner of the homeless encampment msn.com - April 9 at 2:18 PM
	City of Neptune Beach unveils new water tower design msn.com - April 7 at 1:48 PM
	Gunbattle between Haitian police and gangs paralyzes area near National Palace saratogian.com - April 2 at 1:45 AM
	The Wellness Innovation Summit at the Knoxville Convention Center Saturday, April 6th wate.com - April 1 at 10:44 AM
	SNAPSHOT: Construction supervisor credits BOCES with building him a solid foundation for his future saratogian.com - April 1 at 10:44 AM
	Wellness Wednesday – Focusing on Cardiovascular Health nwahomepage.com - March 28 at 6:30 PM
	Food Encapsulation Market Industry Chain Information, Emerging Market Regions (2024-2032) taiwannews.com.tw - March 28 at 6:30 PM
	SNAPSHOT: The Bunker celebrates opening of newest location in Saratoga Springs saratogian.com - March 25 at 8:40 AM
	SNAPSHOT: Capital Region BOCES event will link students to employers and recruiters saratogian.com - March 24 at 9:05 AM
	Kingdom Wellness & Dispensary opens new retail location westsidenewsny.com - March 18 at 12:39 PM
	Wellness expo promotes better health within Black families ksdk.com - March 17 at 8:17 PM
	Rooted Wellness celebrates grand opening lowellsun.com - March 15 at 8:16 PM
	Clinton to host Mayor's Wellness Program on Saturday, March 23 newjerseyhills.com - March 15 at 3:15 PM
	Your Weekly Horoscopes: March 17 to 23, 2024 purewow.com - March 15 at 12:13 AM
	Healthwise Wellness hosts clinic open house arkansasonline.com - March 13 at 7:38 AM
	Southwell Center for Healing and Wellness to permanently close msn.com - March 12 at 12:26 AM
	Neptune Software: 'Environmental Supply Chains - You Don't Need to Sacrifice Profitability to Act Sustainably' tmcnet.com - March 11 at 2:25 PM
	Neptune Wellness Solutions Inc. wsj.com - March 9 at 8:59 AM
	Neptune Wellness appoints Michael De Geus as interim president, CEO msn.com - March 8 at 9:40 AM
	Neptune Appoints Interim President and CEO and Interim COO accesswire.com - March 8 at 8:30 AM
	Neptune Wellness to be delisted from Nasdaq investing.com - March 8 at 12:42 AM
	Top Marijuana Stocks For Trading Today 2024 marijuanastocks.com - March 6 at 9:06 AM
	Neptune Announces Decision of Nasdaq Hearings Panel To Delist Common Shares accesswire.com - March 6 at 8:30 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 months
April 26, 2024 3:21 AM
View Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 months
3 Stocks Leading the U.S. Agriculture Comeback
April 26, 2024 10:10 AM
View 3 Stocks Leading the U.S. Agriculture Comeback
5 Trends You Need to Know This Quarter
April 13, 2024 9:16 AM
View 5 Trends You Need to Know This Quarter
Analysts Agree, This Could Be Tyson Stock’s Comeback Year
April 23, 2024 6:05 AM
View Analysts Agree, This Could Be Tyson Stock’s Comeback Year

All Headlines

Company Descriptions

CNS Pharmaceuticals

NASDAQ:CNSP

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc., Reata Pharmaceuticals, Inc., Pomeranian Medical University, and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. The company was incorporated in 2017 and is based in Houston, Texas.

Enveric Biosciences

NASDAQ:ENVB

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead program is EB-373, an active metabolite of psilocybin, which is in Phase 1 clinical trials for the treatment of anxiety disorders; EVM-301 for treating mental health; and EV104 CBD + Celecoxib conjugate for treating osteoarthritis. The company also developing cannabinoid-infused topical product for the treatment of radiodermatitis; and cannabinoid and COX-2 inhibitor conjugation that is in pre-clinical stage for the treatment of OA/acute pain. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

GRI Bio

NASDAQ:GRI

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

Neptune Wellness Solutions

NASDAQ:NEPT

Neptune Wellness Solutions Inc., a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial